Hans W Nijman (H W Nijman)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Neoadjuvant Chemotherapy

Endometrial Cancer

Top Venues

British journal of cancer

Nature communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anneke L Eerkens, Koen Brummel, Annegé Vledder, Sterre T Paijens, Marta Requesens, Dominik Loiero, Nienke van Rooij, Annechien Plat, Floris-Jan Haan, Patty Klok, Refika Yigit, Thijs Roelofsen, Natascha M de Lange, Rie Klomp, David N Church, Arja Ter Elst, Rene Wardenaar, Diana Carolina Johanna Spierings, Floris Foijer, Viktor Hendrik Koelzer, Tjalling Bosse, Joost Bart, Mathilde Jalving, Anna K L Reyners, Marco de Bruyn, Hans W Nijman
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study. Nature communications 15 (1) (2024)
Anneke L Eerkens, Koen Brummel, Annegé Vledder, Sterre T Paijens, Marta Requesens, Dominik Loiero, Nienke van Rooij, Annechien Plat, Floris-Jan Haan, Patty Klok, Refika Yigit, Thijs Roelofsen, Natascha M de Lange, Rie Klomp, David N Church, Arja Ter Elst, Rene Wardenaar, Diana Carolina Johanna Spierings, Floris Foijer, Viktor Hendrik Koelzer, Tjalling Bosse, Joost Bart, Mathilde Jalving, Anna K L Reyners, Marco de Bruyn, Hans W Nijman
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study. Nature communications 15 (1) (2024)
Lisa Vermij, Jan J Jobsen, Alicia León-Castillo, Mariel Brinkhuis, Suzan Roothaan, Melanie E Powell, Stephanie M de Boer, Pearly Khaw, Linda R Mileshkin, Anthony Fyles, Alexandra Leary, Catherine Genestie, Ina M Jürgenliemk-Schulz, Emma J Crosbie, Helen J Mackay, Hans W Nijman, Remi A Nout, Vincent T H B M Smit, Carien L Creutzberg, Nanda Horeweg, Tjalling Bosse, null null
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. British journal of cancer (2023)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Prognostic benefit of TILs independent of clinicopathological and molecular factors. British journal of cancer (2023)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer 128 (3) (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer 128 (3) (2022)
Koen Brummel, Anneke L Eerkens, Marco de Bruyn, Hans W Nijman
Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer 128 (3) (2022)
S T Paijens, A Vledder, D Loiero, E W Duiker, J Bart, A M Hendriks, M Jalving, H H Workel, H Hollema, N Werner, A Plat, G Bea A Wisman, R Yigit, H Arts, A J Kruse, N M de Lange, V H Koelzer, M de Bruyn, Hans W Nijman
Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients. Oncoimmunology 10 (1) (2021)
Cornelis J M Melief, Marij J P Welters, Ignace Vergote, Judith R Kroep, Gemma G Kenter, Petronella B Ottevanger, Wiebren A A Tjalma, Hannelore Denys, Mariette I E van Poelgeest, Hans W Nijman, Anna K L Reyners, Thierry Velu, Frederic Goffin, Roy I Lalisang, Nikki M Loof, Sanne Boekestijn, Willem Jan Krebber, Leon Hooftman, Sonja Visscher, Brent A Blumenstein, Richard B Stead, Winald R Gerritsen, Sjoerd H Van der Burg
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival. Science translational medicine 12 (535) (2021)
Arjan Kol, Joyce M Lubbers, Anouk L J Terwindt, Hagma H Workel, Annechien Plat, G Bea A Wisman, Joost Bart, Hans W Nijman, Marco De Bruyn
Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer. Oncoimmunology 10 (1) (2021)
Kim L Brunekreeft, Sterre T Paijens, Maartje C A Wouters, Fenne L Komdeur, Florine A Eggink, Joyce M Lubbers, Hagma H Workel, Elisabeth C Van Der Slikke, Noor E J Pröpper, Ninke Leffers, Julien Adam, Harry Pijper, Annechien Plat, Arjan Kol, Hans W Nijman, Marco De Bruyn
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome. Oncoimmunology 9 (1) (2020)
Hans H B Wenzel, Roy F P M Kruitwagen, Hans W Nijman, Ruud L M Bekkers, Toon Van Gorp, Cornelis D de Kroon, Luc R C W van Lonkhuijzen, Leon F A G Massuger, Ramon G V Smolders, Nienke E van Trommel, Refika Yigit, Ronald P Zweemer, Maaike A van der Aa
Short-term surgical complications after radical hysterectomy-A nationwide cohort study. Acta obstetricia et gynecologica Scandinavica 99 (7) (2020)
Stephanie van de Wall, Karl Ljungberg, Peng Peng Ip, Annemarie Boerma, Maria L Knudsen, Hans W Nijman, Peter Liljeström, Toos Daemen
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology 7 (10) (2018)
Fenne L Komdeur, Thalina M Prins, Stephanie van de Wall, Annechien Plat, G Bea A Wisman, Harry Hollema, Toos Daemen, David N Church, Marco de Bruyn, Hans W Nijman
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology 6 (9) (2017)